Cargando…
Plasma proteomic signatures predict dementia and cognitive impairment
INTRODUCTION: Biomarker discovery of dementia and cognitive impairment is important to gather insight into mechanisms underlying the pathogenesis of these conditions. METHODS: In 997 adults from the InCHIANTI study, we assessed the association of 1301 plasma proteins with dementia and cognitive impa...
Autores principales: | Tanaka, Toshiko, Lavery, Robert, Varma, Vijay, Fantoni, Giovanna, Colpo, Marco, Thambisetty, Madhav, Candia, Julian, Resnick, Susan M., Bennett, David A., Biancotto, Angelique, Bandinelli, Stefania, Ferrucci, Luigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7210784/ https://www.ncbi.nlm.nih.gov/pubmed/32607407 http://dx.doi.org/10.1002/trc2.12018 |
Ejemplares similares
-
Plasma proteomic signature of the risk of developing mobility disability: A 9‐year follow‐up
por: Osawa, Yusuke, et al.
Publicado: (2020) -
Plasma proteomic biomarker signature of age predicts health and life span
por: Tanaka, Toshiko, et al.
Publicado: (2020) -
Unbiased proteomics and multivariable regularized regression techniques identify SMOC1, NOG, APCS, and NTN1 in an Alzheimer’s disease brain proteomic signature
por: Roberts, Jackson A., et al.
Publicado: (2023) -
Plasma proteomic signature of age in healthy humans
por: Tanaka, Toshiko, et al.
Publicado: (2018) -
Proteomic Mediators of Overall Cardiovascular Health on All-Cause Mortality
por: Tanaka, Toshiko, et al.
Publicado: (2023)